Showing 35,310 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined aidsmap in 2008 and was Managing Editor from 2018 to 2024. As a freelancer, he now edits aidsmap’s news and conference coverage, as well as working on updates to About HIV pages. He is also a contributing science editor for TheBodyPro, a freelance journalist for The Lancet HIV, and a medical writer helping researchers prepare articles for peer-reviewed journals. He began working on HIV at Gay Men Fighting AIDS in the mid-1990s.

HIV testing programmes & uptake

Programs Designed to Promote HIV Testing May Worsen Misinformation, Stigma

Editor's pick
Infectious Disease Advisor
26 September 2022
Coronavirus

The Haunting of (Long) COVID: Why the Pandemic Isn’t Over, and How It Affects PLWH

Editor's pick
TheBodyPro
26 September 2022
People who inject drugs

HIV spike among B.C. drug users associated with COVID-19-related service closures, research says

Editor's pick
CBC
26 September 2022
Mpox

Second vaccine doses to be offered to those at highest risk from monkeypox

Editor's pick
UK Health Security Agency
26 September 2022
Climate change

Food insecurity among women in sub-Saharan Africa doubles the risk of HIV acquisition

News
26 September 2022
HIV prevention policy

To Meet Global HIV Prevention Goals, Expand The PEPFAR-FDA Tentative Approval Pathway

Editor's pick
Health Affairs
25 September 2022
Sexual health

What do healthcare workers really think of mHealth?

Editor's pick
Be In The Know
23 September 2022
New & experimental HIV treatments

Merck restarts islatravir HIV treatment studies, but abandons monthly PrEP

News
23 September 2022
TB treatment

South Africa to expedite TB diagnosis/treatment as cases continue to soar

Editor's pick
Medical Brief
22 September 2022
Mpox

England's Health Secretary must prioritise monkeypox's devastating impact on sexual health services

Editor's pick
Terrence Higgins Trust
22 September 2022
Climate change

When Drought and HIV Collide

Editor's pick
Yarrow Global
22 September 2022
Finance & funding

Global Fund Partners Pledge Record Level of Support to End Deadly Diseases, Prevent Future Pandemics

Editor's pick
The Global Fund
22 September 2022
Finance & funding

Global Fund Still Short of $18 Billion Target – But UK and Italy Have Yet to Announce Pledges

Editor's pick
Health Policy Watch
22 September 2022
Harm reduction

After 21 years, Sydney’s supervised injecting centre model is hard to improve

Editor's pick
Cosmos
22 September 2022
Opportunistic infections

Varicella Zoster Virus Linked to High Morbidity, Health Care Costs in Patients With HIV

Editor's pick
Infectious Disease Advisor
21 September 2022
The search for a cure

License to Kill: Latency HIV-CRISPR pinpoints how to blow latent HIV’s cover

Editor's pick
Fred Hutch
21 September 2022
People who inject drugs

Success in containing and treating HIV among people injecting drugs in the UK has stalled in recent years

News
21 September 2022
Sexual health

STDs Chlamydia, Syphilis, Gonorrhea Increased in US in 2021

Editor's pick
Bloomberg
20 September 2022
Mpox

A Monkeypox Update From Clinicians on the Front Lines

Editor's pick
TheBodyPro
20 September 2022
Global health initiatives

Global Fund gets powerful help with $18 billion funding goal

Editor's pick
Associated Press
20 September 2022

aidsmap news: US regulator’s decision on vaginal ring denies choice to women who need HIV prevention, 20 September 2022

September 2022
New & experimental HIV treatments

Merck to Initiate New Phase 3 Clinical Program with Lower Dose of Daily Oral Islatravir in Combination with Doravirine for Treatment of People with HIV-1 Infection

Editor's pick
Merck press release
20 September 2022
News about aidsmap

Facts not fear: NAM at 35

News
20 September 2022
PrEP programmes & uptake

PrEParing for the next chapter of HIV prevention in Myanmar

Editor's pick
UNAIDS
20 September 2022